| First Author | Buer J | Year | 1998 |
| Journal | J Exp Med | Volume | 187 |
| Issue | 2 | Pages | 177-83 |
| PubMed ID | 9432975 | Mgi Jnum | J:118977 |
| Mgi Id | MGI:3700888 | Doi | 10.1084/jem.187.2.177 |
| Citation | Buer J, et al. (1998) Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 187(2):177-83 |
| abstractText | Continuous antigenic stimulation in vivo can result in the generation of so-called 'anergic' CD4(+) or CD8(+) T cells that fail to proliferate upon antigenic stimulation and fail to develop cytolytic effector functions. Here we show that class II major histocompatibility complex-restricted T cells specific for influenza hemagglutinin (HA) that become anergic in mice expressing HA under control of the immunoglobulin kappa promoter exhibit an impaired effector function in causing diabetes in vivo, as compared to their naive counterparts, when transferred into immunodeficient recipients expressing HA under the control of the insulin promoter. Furthermore, HA-specific T cells anergized in vivo contain higher levels of interleukin (IL)-4 messenger RNA (mRNA) than naive and recently activated T cells with the same specificity and more than a 100-fold higher levels of IL-10 mRNA. The higher expression of the IL-10 gene is also evident at the protein level. These findings raise the interesting possibility that T cells rendered anergic in vivo have in fact become regulatory T cells that may influence neighboring immune responses through the release of IL-10. |
